Omani Delegation Visit to Houston St. Luke’s Episcopal Health System

2 Texas Medical Center Founded 60 years ago. The largest medical center in the world covering 1,000 acres (6,856 m2) with 47 non-profit health institutions dedicated to patient care, research and education. 13 world renowned hospitals and 2 medical schools University of Texas Health Science Center Baylor College of Medicine $9 billion annual operating budget 10,000+ MDs and PhDs 4 nursing schools: 26,000+ registered nurses, LVNs, technicians and medical support staff 5.1 million patient visits with more than 14,000 international patients annually 72,000+ employees Texas Medical Center Houston, Texas

3 St. Luke’s Health System St. Luke's Episcopal Health System comprises: St. Luke’s Episcopal Hospital, Texas Medical Center St. Luke’s Episcopal Health Charities St. Luke’s The Woodlands Hospital St. Luke’s Sugar Land Hospital St. Luke’s Lakeside Hospital Kelsey-Seybold Management. LLP In a period of rapid growth, the Health System moves into the suburbs of Houston to care for people where they live. Our reputation for providing high-quality, compassionate healthcare precedes us. As more people live far from the city's core, St. Luke's will be there with our exemplary brand of care.  

4 Aerial view of St. Luke’s Episcopal Hospital Main Building, O’Quinn Medical Tower and the Texas Heart Institute at St. Luke’s Episcopal Hospital - Denton A. Cooley Building

5 St. Luke’s Hospital Facts Serves as the adult clinical partner for Texas Heart Institute Tertiary acute care teaching hospital in the Texas Medical Center, caring for patients from the Greater Houston area and patients from more than 70 countries with over 500 physicians on active staff. 23 clinical specialties with eight ranking in the nation’s top 50 centers in Cardiology; Digestive Disorders; Endocrinology; Geriatrics; Kidney Disease; Neurology and Neurosurgery; Respiratory Disorders; and Urology by U.S. News & World Report. Licensed for 912 beds; 157 critical care beds; 48 operating rooms, 13 cardiac catheterization labs. Adult teaching hospital affiliated with Baylor College of Medicine, The University of Texas Medical School at Houston, Texas Heart®Institute, and with The University of Texas System in Austin.

6 Texas Heart Institute and St. Luke’s Episcopal Hospital Expansion At the flagship in the Texas Medical Center, Texas Heart Institute and St. Luke’s Episcopal Hospital is under construction.

7 Annual Facts 2009 Over USD $1 billion in patient revenue Active medical staff: 562 with 67% board certified Employees: 4,335 (including 1,459 RNs) Annual adult admissions: 32,000+ Outpatient visits: 205,000+ Emergency Department visits: 28,000+ Minor Emergency Department visits: 50,000+ Radiology procedures: 300,000+ Lab tests: 3.4 million

8 Texas Heart® Institute at St. Luke’s Episcopal Hospital The Texas Heart Institute (THI) was founded in 1962 by Dr. Denton A. Cooley for the study and treatment of diseases of the heart and blood vessels; dedicated to research, education and training of future professionals. Its mission is to eliminate cardiovascular disease worldwide through innovative research and the training of outstanding students, scientists and physicians. Since 1962, more than 2,700 specialists from 44 states and 47 countries have been trained at THI. The Texas Heart Institute at St. Luke’s Episcopal Hospital – The Denton A. Cooley Building, primary facility of THI

9 Medical Excellence For 19 years in a row Texas Heart Institute at St. Luke’s Episcopal Hospital has been ranked among the Top 10 Heart and Heart Surgery Centers in the United States by the U.S. News & World Report

10 THI Experience 40 years of training the world experts in cardiology and CV surgery. More than 115,000 open heart surgeries and 1,000 heart transplants—experience unrivaled in the world—by the surgical team led by Dr. Denton A. Cooley. More than 227,000 cardiac catheterization procedures. Unparalleled experience  in mechanical circulatory support devices — more than 600 have been implanted with 12 new clinical trials underway.

11 Firsts First successful human heart transplantation in the U.S. First implantation in the world of a total artificial heart. First to receive FDA approval in the U.S. for HeartMate II – for Continuous Flow Chronic Left-Ventricular Assist System (LVAS) and one of the primary centers to have FDA approval for the study of VADs to serve as destination therapies. First implantation of the Jarvik 2000®, ventricular assist device AbioCorTM – total replacement artificial heart – the U.S. site with the most experience and 1 of 4 centers to recently receive FDA approval to use the device as a bridge to transplant. First in the world to receive FDA approval and to treat patients with severe heart failure and coronary heart disease with their own stem cells.

12 Pioneering Research One of only five centers in the U.S. selected by the National Institutes of Health to support a new national consortium called the Cardiovascular Cell Therapy Research Network to study stem cell treatments for patients with cardiovascular disease. This network is the first recipient of federal funding for studies using stem cells taken from patients’ own bodies. THI physician scientists are paving the way for a new era of medicine by identifying genes and proteins that cause cardiovascular diseases. By identifying genetic risks, physician scientists can find promising treatments, isolate environmental threats and assess how to modify human behavior to improve health. Physician scientists at THI have amassed the world’s greatest experience in the development and use of ventricular assist devices (VADs) to sustain the failing circulation in patients with severe heart failure. More than a dozen different VADs are being studied in clinical trials, even more are under development in preclinical studies and THI recently received a $2.8 million federal grant to develop a novel artificial heart.

13 Pioneers in Mechanical Heart Devices Denton A. Cooley, MD – President and Surgeon-in-Chief, THI; Chief, Cardiovascular Surgery, St. Luke’s O.H. Frazier, MD – Director, Surgical Research, Chief, Cardiopulmonary Transplantation THI; Chief, Transplant Service, St. Luke’s

14 12 uniquely designed surgical suites dedicated to cardiovascular surgery. 650ft2 (60m2) with 2 observation domes that allow for educational activities. Telemedicine capabilities in the OR can connect physicians and students from all over the world broadcasting the latest procedures. CV Surgical Suites

15 Largest configuration of laboratories in the world with 13 contiguous units 3 dedicated electrophysiology laboratories, one of which uses the Stereotaxis Remote Navigation System 15,000 procedures each year averaging approximately 42 a day. Leading the world in development of minimally invasive and percutaneous diagnostic and therapeutic procedures for: Coronary Artery, Aortic, Carotid Artery, Peripheral Artery, Heart Valve and Heart Rhythm diseases Cardiac Catheterization Laboratories

16 Latest Technology 3 daVinci Robots: minimally invasive robotic cardiac surgery Hybrid Surgical Suites daVinci Robot 2 hybrid surgical suites: surgical and catheterization capabilities combined

17 Latest Technology Advanced Radiosurgery with CyberKnife®

18 Pioneering in Neurovascular Efforts Designated as a “Neuroscience Center of Excellence,” according to the 2006-2007 Neuroscience Center of Excellence Survey. It is the only center in Houston, and one of only four healthcare centers in Texas to receive this honor. St. Luke's is the only hospital in the world using the state-of-the-art Artis Zeego robotic device to provide advanced imaging capabilities during complex neuro-interventional procedures, like the diagnosis and treatment of stroke and brain aneurysms. Artis Zeego Robot Michel Mawad, MD Chief, Neurovascular Service, St. Luke’s

19 Excellence in Nursing First in Texas to be recognized with back-to-back Magnet Award for nursing excellence. 1,459 registered nurses with 32% board certified in their specialty. 1.53 ratio of RNs to beds. Affiliated with Texas Woman’s University, the University of Texas, the University of Texas Medical Branch (Galveston), Houston Baptist University and others.

20 Clinical Excellence St. Luke’s earned the Distinguished Hospital award for Clinical Excellence™ from HealthGrades two years in a row, placing St. Luke’s among top 5% of all hospital in the U.S. HealthGrades has also awarded St. Luke’s for performing in the top 10 percent in the nation in the following specialty categories: Stroke Care, six years in a row Pulmonary Care, four years in a row Gastrointestinal Care/Surgery, four years in a row Vascular Surgery General Surgery Cardiac Care Critical Care

21 Other Recognitions The lowest mortality ratio in comparison to other non-profit academic medical centers across the nation, according to University HealthSystem Consortium’s for the following specialties: Cardiology Neurosurgery General Surgery Medical Oncology General Medicine The American College of Radiology recognized St. Luke’s Women’s Center as Houston’s first “Breast Imaging Center of Excellence.” FORTUNE and Houston Business Journal recognition as one of “100 Best Companies to work for.”

22 What We Can Deliver: This outreach effort would be accomplished through a comprehensive strategy that includes, but is not limited to: Education: development of local program to attract and train students, scientists and physicians from the region through faculty in residence, exchange, teleconferencing and related medical staff development programs that would be designed to achieve superior medical staff. Same focus would be given to Nursing and Allied Health personnel. Clinical Consulting/Protocols drawing on each partner’s in-depth historical pioneering expertise and leadership in the clinical arena transferring this knowledge directly to the project. Administrative Management and Operation: sharing of current and latest programs coupled with each partner’s expertise in order to maximize the efficient, highest quality, most cost effective delivery of the center’s non-clinical services. Research Collaboration: the development and implementation of latest clinical trials programs – several tailored directly for the region’s specific disease needs that will support the advancement of science and treatments locally and globally. Focus on translational research with advances delivered efficiently to bedside.